Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Change in Acquisitions & Divestments (2018 - 2022)

TransMedics (TMDX) has 4 years of Change in Acquisitions & Divestments data on record, last reported at $28.7 million in Q3 2022.

  • For Q3 2022, Change in Acquisitions & Divestments rose 4.24% year-over-year to $28.7 million; the TTM value through Dec 2022 reached $76.9 million, down 26.61%, while the annual FY2022 figure was $76.9 million, 26.61% down from the prior year.
  • Change in Acquisitions & Divestments reached $28.7 million in Q3 2022 per TMDX's latest filing, down from $33.8 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $37.8 million in Q2 2021 and bottomed at $750000.0 in Q3 2018.
  • Average Change in Acquisitions & Divestments over 4 years is $19.7 million, with a median of $18.7 million recorded in 2020.
  • The widest YoY moves for Change in Acquisitions & Divestments: up 100.42% in 2021, down 38.67% in 2021.
  • A 4-year view of Change in Acquisitions & Divestments shows it stood at $750000.0 in 2018, then skyrocketed by 3922.27% to $30.2 million in 2020, then plummeted by 38.67% to $18.5 million in 2021, then surged by 54.95% to $28.7 million in 2022.
  • Per Business Quant database, its latest 3 readings for Change in Acquisitions & Divestments were $28.7 million in Q3 2022, $33.8 million in Q2 2022, and $14.5 million in Q1 2022.